STK16-IN-1

Catalog No. :
ACBOJI319
CAS No. :
1223001-53-3
Molecular Formula :
C17H12FN3O
Molecular Weight :
293.30

IUPAC Name:1-(4-fluoro-3-methylphenyl)-1,6-dihydro-2H-pyrrolo[2,3-h][1,6]naphthyridin-2-one

STK16-IN-1 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg99%$57.00Login to see priceInquiryInquiry
10mg99%$97.00Login to see priceInquiryInquiry
25mg99%$181.00Login to see priceInquiryInquiry
50mg99%$283.00Login to see priceInquiryInquiry
100mg99%$451.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSTK16-IN-1
IUPAC Name1-(4-fluoro-3-methylphenyl)-1,6-dihydro-2H-pyrrolo[2,3-h][1,6]naphthyridin-2-one
Molecular FormulaC17H12FN3O
Molecular Weight293.30
SMILESO=C(C=CC1=CN2)N(C3=CC=C(F)C(C)=C3)C1=C4C2=NC=C4
InChI KeyWQNRDXHKVSKUPI-UHFFFAOYSA-N
SynonymSCHEMBL1368254 | 1-(4-fluoro-3-methylphenyl)-1H-pyrrolo[2,3-h][1,6]naphthyridin-2(7H)-one | YYB00153 | 1-(4-Fluoro-3-methylphenyl)-1,7-dihydro-2H-pyrrolo[2,3-h][1,6]naphthyridin-2-one | BCP20541 | 1-(4-fluoro-3-methylphenyl)-1H,2H,7H-pyrrolo[2,3-h]1,6-nap
CAS No.1223001-53-3
PubChem CID58525066

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACBOJI319 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBOJI319 route product structure diagram
    ACBOJI3191223001-53-3
Inquiry

2. ACBOJI319 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEITN214 route compound structure diagram
    ACEITN214139911-27-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBOJI319 route product structure diagram
    ACBOJI3191223001-53-3
Inquiry

Comments (0)